Rochester Multiple Sclerosis Center

Rochester, New York

Academic MS Center
4 Active TrialsInfusion CenterLarge Center
25 MS centers statewide · Ranked #5 in New York for clinical trials
What kind of place is this?
Comprehensive Care TeamResearch FocusedPart of Major Health SystemInfusion On-Site

You’re coming to an academic MS center that blends specialty care with teaching and research. You’ll likely appreciate the large multidisciplinary team, on-site infusion services, and access to advanced testing and studies. Because this is a large academic center, getting care may feel less convenient than at a smaller local clinic.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research5/5
Insurance & Navigation Help3/5
Scheduling & Virtual Care1/5

About Rochester Multiple Sclerosis Center

This center combines pediatric and adult MS care within a major academic medical system. It also offers on-site infusion treatment and an active clinical research program, making it a strong option for patients who want both specialty care and study access.

Rochester Multiple Sclerosis Center provides diagnosis and management of multiple sclerosis, including relapsing-remitting and primary progressive forms, as well as related immune disorders of the nervous system. The center cares for both pediatric and adult patients and serves a large regional patient population. You can also receive support from a multidisciplinary team and get care delivered alongside an on-site infusion center. For patients interested in studies, the center has an active research program with clinical trials.

Rochester Multiple Sclerosis Center is part of UR Medicine Multiple Sclerosis Center & Immunology at the University of Rochester Medical Center. You'll find care for both children and adults with multiple sclerosis, along with related neuroimmunologic diseases. The center brings together neurologists, nurses, advanced practice providers, social workers, research nurse coordinators, and infusion nurses. Patients also have access to on-site infusion care, diagnostic testing, and a research program.

Featured Care Team Members

Andrew D. Goodman, M.D.
Director
Multiple sclerosis and neuroimmunology

Specialized Programs

pediatric MS care
adult MS care
neuroimmunology fellowship
comprehensive care clinic
research program

Services & Treatments

What They Treat
multiple sclerosisrelated neuroimmunologic diseasesimmune disorders of the nervous systemprimary progressive multiple sclerosisrelapsing-remitting multiple sclerosisrelapsing forms of multiple sclerosisNMDAR encephalitis
How They Treat It
Expert care for children and adults with multiple sclerosisCare for related neuroimmunologic diseasesDiagnosis of multiple sclerosisManagement of multiple sclerosisClinical research participationFellowship trainingmedicationphysical therapyspeech therapyoccupational therapyfenebrutinibocrelizumabalemtuzumabinebilizumabibudilast
Diagnostics
complete medical historyneurological examinationcomputed tomography (CT) scanningmagnetic resonance imaging (MRI)spinal fluid laboratory testsbloodworkPatient-Reported Outcomesdisability measures

Research & Clinical Trials

This center is currently involved in 4 clinical trials — ranked #5 in New York for active trials

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE3
Autologous Hematopoietic Stem Cell TransplantationBest Available Therapy (BAT)
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
The Cleveland Clinic
ACTIVE NOT RECRUITINGPHASE4
Early Highly Effective Therapies GroupEscalation Therapies Group
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE4
OcrelizumabPlacebo for Ocrelizumab

Insurance & Access

Contact
601 Elmwood Ave Box 605, Rochester, NY 14642
Insurance & Support
Care Coordinator

FAQs from Rochester Multiple Sclerosis Center

Yes. The center provides expert care for both children and adults with multiple sclerosis.

Yes. The center has an on-site infusion center, so infusion care can be part of your treatment plan there.

The center treats multiple sclerosis, including relapsing-remitting and primary progressive forms, along with related neuroimmunologic diseases and immune disorders of the nervous system.

Yes. The center has an active research program and clinical trials, including studies in multiple sclerosis.

Your care may include neurologists, nurses, advanced practice providers, social workers, research nurse coordinators, and infusion nurses. The center also has a care coordinator to help support care delivery.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Website